
Alkylating drugIndian prescription status not found in lists checkedOn NLEM 2022NPPA price ceilingJan Aushadhi listed
Cyclophosphamide
सिक्लोफोस्फामाइड
Cyclophosphamide capsules are a cytotoxic alkylating drug for certain cancers, including lymphomas, myeloma and leukemias, and for childhood minimal change nephrotic syndrome. It can suppress bone marrow and immunity, harm the bladder and fetus, and needs close blood monitoring. Ask your doctor or pharmacist before use.
- Generic name
- Cyclophosphamide
- Used for
- Treating certain cancers and, in children, minimal change nephrotic syndrome.
- Label used
- Capsules label, oral, DailyMed set 0e1cb955, effective 2025-01
- Prescription status (India)
- Not found in the Schedule H/H1/X/G lists we checked
- On NLEM 2022
- Yes (Tablet 50 mg; Powder for Injection 500 mg; Injection 100 mg/vial)
- NPPA price ceiling
- Yes (scheduled formulation)
More facts
- Jan Aushadhi
- Listed (1 product row)
- Banned combinations
- None found in the list we checked
Compiled from official drug labels and Indian government sources. Always follow your doctor's or pharmacist's advice.
Safety at a glance
- AlcoholNot mentioned in label text
- PregnancyCaution in label textSee wording
- BreastfeedingCaution in label textSee wording
- DrivingNot mentioned in label text
- KidneyCaution in label textSee wording
- LiverCaution in label textSee wording
Taken only from the label text cited on this page. "Not mentioned" does not mean safe. Ask your doctor or pharmacist.
What is cyclophosphamide used for?
The label describes treatment of malignant diseases such as Hodgkin's and other lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma and breast carcinoma.
It is also used in children with biopsy-proven minimal change nephrotic syndrome who did not respond to or cannot tolerate corticosteroids. Safety in adult nephrotic syndrome is not established.
- Lymphomas and multiple myeloma
- Leukemias
- Breast, ovarian cancer, neuroblastoma, retinoblastoma
- Childhood minimal change nephrotic syndrome
It treats certain cancers and a childhood kidney condition.
Source1
How does cyclophosphamide work?
The label says the mechanism is thought to involve cross-linking of tumor cell DNA.
It is thought to damage cancer cell DNA by cross-linking.
Source1
How is cyclophosphamide usually taken?
This page covers the US label for cyclophosphamide capsules taken by mouth, with the dosing the label gives for adults and, where the label says so, children.
This is label-level information, not personal advice. Indian pack labels may differ, and your prescriber's instruction always comes first.
For adults and children with malignant disease, the label describes 1 mg to 5 mg per kg by mouth once daily for initial and maintenance dosing, adjusted to response and blood counts.
For childhood nephrotic syndrome it describes 2 mg per kg once daily for 8 to 12 weeks. Treatment beyond 90 days increases the chance of sterility in males.
Capsules are taken in the morning, swallowed whole, with plenty of fluids to reduce urinary tract toxicity. They must not be opened, chewed or crushed, and handled as a cytotoxic drug.
- 1 to 5 mg per kg once daily for cancer
- 2 mg per kg for 8 to 12 weeks in nephrotic syndrome
- Take in the morning with plenty of fluid
- Swallow whole; do not open or crush
Taken once daily in the morning, swallowed whole with plenty of fluid, at a dose based on weight.
Source1
What are the side effects of cyclophosphamide?
Common
- The label lists neutropenia, febrile neutropenia, fever, hair loss, nausea, vomiting and diarrhea as reported most often.
- Low white cells and fever
- Hair loss
- Nausea and vomiting
- Diarrhea
- Bladder irritation or bleeding
Serious: get help
- Serious effects include infections, bone marrow failure, bladder bleeding (hemorrhagic cystitis), heart and lung toxicity, liver veno-occlusive disease, secondary cancers and infertility.
Low blood counts, infections, hair loss and nausea are common; bladder, heart and lung harm can be serious.
Source1
Who should be careful with cyclophosphamide?
It is contraindicated with a history of severe allergy to cyclophosphamide or its metabolites, and with urinary outflow obstruction.
The label warns of bone marrow suppression, serious infections, urinary and kidney toxicity, heart and lung toxicity and harm to the fetus. Pregnancy status should be checked first, with contraception during and after treatment (1 year for females, 4 months for males). It can cause infertility.
- Allergy to cyclophosphamide
- Urinary outflow obstruction
- Serious infections and low blood counts
- Fetal harm; use contraception
- Infertility
It can suppress blood counts, harm the bladder and fetus, and needs close blood monitoring.
Source1
What medicines interact with cyclophosphamide?
- Protease inhibitors
- ACE inhibitors, thiazide diuretics, zidovudine
- Anthracyclines, trastuzumab
- Amiodarone
- Protease inhibitors may raise toxic metabolite levels.
- ACE inhibitors, natalizumab, paclitaxel, thiazide diuretics and zidovudine may add to blood and immune toxicity.
- Anthracyclines, cytarabine, pentostatin, trastuzumab and cardiac radiation may add heart toxicity, and amiodarone may add lung toxicity.
No match in this label text. Ask your pharmacist about any medicine you take.
Several medicines can add to its blood, heart or lung toxicity.
Source1
How should cyclophosphamide be stored?
The label gives a storage range of 20 to 25 degrees C.
Follow the storage line on your own pack, and keep medicines out of the reach of children.
Follow the storage instructions on your pack.
Source1
Is cyclophosphamide a prescription medicine in India?
We did not find cyclophosphamide in the Drugs Rules 1945 Schedule H, H1, X or G rows we checked, so we cannot state its Indian prescription status from our lists. Ask your pharmacist or doctor.
Cyclophosphamide is on the National List of Essential Medicines 2022. Listed forms include: Tablet 50 mg (page 81); Powder for Injection 500 mg (page 81); Injection 100 mg/vial (page 81).
NPPA lists ceiling prices for scheduled cyclophosphamide formulations. The table shows the rows we found. Check NPPA directly for the current list.
The Jan Aushadhi (PMBJP) list we checked has 1 product row that mention cyclophosphamide. We did not capture prices for them.
| List | Formulation and strength | Unit | Ceiling price (Rs) |
|---|---|---|---|
| Anti-cancer, as on March, 2026, page 3 | Tablet 50mg | 1 Tablet | 3.81 |
| Anti-cancer, as on March, 2026, page 3 | Powder for Injection 500mg | 1 Vial | 75.25 |
| All scheduled (NLEM 2015), as on 30.09.2020, page 6 | Tablet 50 mg | 1 Tablet | 4.04 |
| All scheduled (NLEM 2015), as on 30.09.2020, page 6 | Powder for Injection 500 mg | Each Pack | 79.58 |
We did not find cyclophosphamide in the Schedule H, H1, X or G rows we checked, on NLEM 2022 and with NPPA price ceilings.
What is the price ceiling for cyclophosphamide?
NPPA ceiling prices set the most a seller can charge per unit for the listed formulations, before local taxes. They are ceilings, not the price you will always pay.
Jan Aushadhi lists cyclophosphamide products including Cyclophosphamide Injection IP 500 mg 500 mg. We have not shown a price for them. Check the pack and the seller for the actual price.
NPPA lists per-unit ceilings where a formulation is scheduled. Check the pack and seller.
Frequently asked questions
Can I drink alcohol while taking cyclophosphamide?
The label we reviewed does not say. Ask your doctor or pharmacist.
Source1
Is cyclophosphamide safe in pregnancy and breastfeeding?
The label says it can cause fetal harm and describes contraception for 1 year in females and 4 months in males. Ask your doctor or pharmacist.
Source1
Should cyclophosphamide be taken with food?
The label describes taking it in the morning with plenty of fluid. Ask your doctor or pharmacist.
Source1
Can cyclophosphamide affect driving or alertness?
The label we reviewed does not say. Ask your doctor or pharmacist.
Source1
Can children or older adults take cyclophosphamide?
The label describes use in children for malignant diseases and nephrotic syndrome. Ask your doctor or pharmacist.
Source1
Sources
- 1U.S. FDA-approved label (DailyMed) (0e1cb955-99c8-4fe5-89d1-399c8e52174e) Open source · 2026-10-15
- 2National List of Essential Medicines 2022 (81) Open source · 2026-10-15
- 3NPPA price ceiling list (Anti-cancer 3) Open source · 2026-10-15
- 4PMBJP (Jan Aushadhi) product list (p31:sno712) Open source · 2026-10-15
Compiled by software from the sources above and checked by automated rules. Last checked: 2026-10-15 · How we use sources · Report a correction
This information is educational and is not a substitute for advice from your doctor or pharmacist. It does not tell you what dose you personally should take. In an emergency call 112.